The Fine Blueprint of Integrating Immunotherapy and Radiotherapy : From Molecular Mechanisms to Clinical Strategies

Lin-Lin Bu

ISBN 10: 9819636582 / ISBN 13: 9789819636587

Edité par Springer, Springer, 2025

A propos de cet article

Druck auf Anfrage Neuware - Printed after ordering - This book provides a comprehensive overview of the principles and applications of immunotherapy and radiotherapy in the treatment of cancer. It covers the basic concepts of immunotherapy, immunology, radiation physics, radiobiology, and tumor biology, as well as their clinical aspects, such as patient selection, treatment planning, delivery techniques, toxicity management, outcome evaluation, and neoadjuvant approaches. The book also discusses the current challenges and future directions in the field, such as combining immunotherapy and radiotherapy, optimizing the timing and sequencing of treatments, developing novel biomarkers and predictive models, and implementing personalized and adaptive approaches. The book is intended for oncologists, radiation oncologists, medical physicists, radiation therapists, immunologists, researchers, students, and anyone interested in learning more about this rapidly evolving area of cancer therapy.

N° de réf. du vendeur 9789819636587

Détails bibliographiques

• Titre: The Fine Blueprint of Integrating Immunotherapy and Radiotherapy : From Molecular Mechanisms to Clinical Strategies
• Éditeur: Springer, Springer
• Date de parution: 2025
• Langue: anglais
• ISBN à 10 chiffres: 9819636582
• ISBN à 13 chiffres: 9789819636587
• Reliure: Buch
• État de l'article: Neu
• Dimensions: 241 L x 160 H x 22 P (en millimètres) 241 millimètres de largeur par 160 millimètres de hauteur par 22 millimètres de profondeur
• Poids: 709 grammes

A propos de ce titre

Synopsis

This book provides a comprehensive overview of the principles and applications of immunotherapy and radiotherapy in the treatment of cancer. It covers the basic concepts of immunotherapy, immunology, radiation physics, radiobiology, and tumor biology, as well as their clinical aspects, such as patient selection, treatment planning, delivery techniques, toxicity management, outcome evaluation, and neoadjuvant approaches. The book also discusses the current challenges and future directions in the field, such as combining immunotherapy and radiotherapy, optimizing the timing and sequencing of treatments, developing novel biomarkers and predictive models, and implementing personalized and adaptive approaches. The book is intended for oncologists, radiation oncologists, medical physicists, radiation therapists, immunologists, researchers, students, and anyone interested in learning more about this rapidly evolving area of cancer therapy.

À propos de l'auteur

Lin-Lin Bu is an associate professor and associate chief physician of Wuhan University Stomatological Hospital. He obtained his doctoral degrees at Wuhan University Stomatological Hospital, under the mentorship of professors Wen-Feng Zhang and Zhi-Jun Sun. He later conducted postdoctoral research with professor Zhen Gu's team at the University of North Carolina at Chapel Hill and the University of California, Los Angeles. He was selected as a young medical backbone talent in Wuhan and a top young medical talent (first level) in Hubei Province. Dr. Bu has received the "Qiu Weiliu Oral and Maxillofacial Surgery Hope Award" and the "Zhu Yubi Medical Award" from Wuhan University. His research focuses on oral and maxillofacial tumor resection and reconstruction (where he introduced the "Less Is More" concept); oral cancer lymph node metastasis (where he proposed the "PUMP+" principle); the development of biomimetic drug delivery platforms combining medicine and engineering; and innovative teaching methods in head and neck surgery (where he proposed the "PRI-E" teaching model). He has authored 66 first- and corresponding-author papers in prestigious SCI journals. Dr. Bu has also been invited to serve as a guest editor for Seminars in Cancer Biology, Burns and Traum, Journal of Nanobiotechnology and BMC Medical Education.

Qiuji Wu obtained his Ph.D. degree in Oncology from Gustave Roussy Cancer Institute. He is an associate professor and master's supervisor at Wuhan University, and a deputy chief physician at Zhongnan Hospital of Wuhan University. He currently serves as the deputy director and director of Teaching for the Department of Radiation and Medical Oncology (Gynecological Oncology). Dr. Wu's clinical activities primarily focus on the precision radiotherapy and immunotherapy of malignant tumors. He has been selected for the "Global Clinical Scholars Research Training Program (GCSRT)" at Harvard Medical School, the "International Medical Education Faculty Training Program (IMEP)" at the University of Chicago, and the first "Young Clinician Scientist Training Program" at the National Cancer Center of China. His research interests include the role and mechanisms of radiation on cancer immunity and its application in cancer treatment, as well as the mechanisms of radioresistance of cancers. Dr. Wu has led multiple research projects and published more than 40 scientific papers in journals such as Cell Death and Differentiation, Journal of Nanobiotechnology, Journal of Hematology and Oncology, Pharmacological Research, Cancer Communications, International Immunopharmacology, Cancer, Radiatherapy and Oncology, and Immunology.

Bing Liu, M.D., chief physician (Level 1), and doctoral supervisor, is currently the director of the Oral and Maxillofacial-Head and Neck Tumor Surgery Department at Wuhan University Stomatological Hospital. He also serves as the director of the Residency Training Base for the Oral and Maxillofacial Surgery Department Wuhan University Stomatological Hospital. Dr. Liu is the vice chairman of the Oral and Maxillofacial Tumor Integrated Rehabilitation Committee of the Chinese Anti-Cancer Association, a standing member of the Oral and Maxillofacial and Head and Neck Tumor Surgery Committee of the Chinese Stomatological Association, a member of the National Center for Oral Medicine's Oral and Maxillofacial Surgery Alliance Expert Database, and the chairman of the Oral and Maxillofacial Surgery Committee of the Hubei Stomatological Association. His research focuses on both basic and clinical studies related to oral, maxillofacial, and head and neck tumors.